Int 1070-2023
A biotechnology credit against the general corporation tax, the unincorporated business tax, and the corporate tax of 2015.
This bill would renew lapsed tax credits against the General Corporation Tax, the Unincorporated Business Tax, and the Corporate Tax of 2015 for New York City-based companies engaged in biotechnology. The credit shall be allowed for the taxable years beginning on or after January 1, 2023 and before January 1, 2026. The aggregate amount of credit allowable shall not exceed $3,000,000 in a given year. The department of finance shall determine how to allocate the aggregate amount of credit among eligible taxpayers by rule.
DCo-Sponsors (1)
Bill History (13)
Meetings & Hearings (4)
Documents
Files (17)
Int. No. 1070
6/8/2023
Summary of Int. No. 1070
12/20/2024
June 8, 2023 - Stated Meeting Agenda
6/8/2023
Hearing Transcript - Stated Meeting 6-8-23
6/20/2023
Minutes of the Stated Meeting - June 8, 2023
9/21/2023
Committee Report 10/4/23
10/4/2023
Hearing Transcript 10/4/23
10/17/2023
Hearing Testimony 10/4/23
10/17/2023
Proposed Int. No. 1070-A - 11/2/23
11/16/2023
Fiscal Impact Statement
12/18/2023
Committee Report 11/15/23
11/15/2023
November 15, 2023 - Stated Meeting Agenda
11/21/2023
Hearing Transcript 11/15/23
11/20/2023
Hearing Transcript - Stated Meeting 11-15-23
11/25/2023
Int. No. 1070-A (FINAL)
12/18/2023
Local Law 166
1/2/2024
Minutes of the Stated Meeting - November 15, 2023
7/29/2024